Photo AI
Question 10
Read the following passage. BRCA1 and BRCA2 are human genes that code for tumour suppressor proteins. Mutations in BRCA1 and BRCA2 can cause cancer. Specific inheri... show full transcript
Step 1
Answer
Mutations in the BRCA1 and BRCA2 genes alter the DNA sequence that encodes for tumour suppressor proteins. This change can lead to a deficiency in these proteins' ability to regulate cell division, which may promote rapid and uncontrolled cell proliferation. Consequently, the normal mechanisms that prevent the growth of tumors become compromised, significantly increasing cancer risk.
Step 2
Answer
The DNA sample collected from saliva can be amplified using Polymerase Chain Reaction (PCR). The DNA is cut into fragments, which are then separated by gel electrophoresis. Specific primers that target the BRCA1 and BRCA2 genes can be used to identify any mutations present. Finally, sequencing the DNA allows for a comparison to known mutation sequences, thus enabling the identification of harmful mutations.
Step 3
Answer
These drugs, which mimic oestrogen, bind to oestrogen receptors on cancer cells. By occupying these receptors, the drugs prevent actual oestrogen from binding, thereby inhibiting its growth-promoting effects. This action interrupts the signal that stimulates cancer cell proliferation, effectively slowing down or stopping the growth of ER-positive breast tumors.
Step 4
Answer
Blood tests measuring PSA levels are not exclusively indicative of prostate cancer; they can also be elevated due to benign conditions such as infection or inflammation of the prostate. Consequently, elevated PSA levels might result from non-cancerous factors, making it difficult to conclusively diagnose prostate cancer solely based on PSA test results.
Step 5
Answer
Drugs targeting epigenetic modifications can alter the methylation status of oncogenes and tumour suppressor genes. For example, demethylating agents can decrease the methylation of tumor suppressor genes, thereby restoring their expression and function, which is often silenced in cancers. Additionally, histone deacetylase inhibitors can lead to increased acetylation, promoting the transcription of silenced genes, ultimately reversing the effects of epigenetic changes responsible for cancer.
Report Improved Results
Recommend to friends
Students Supported
Questions answered